Evidence map›Paper›PMID 30092777›Full record

ArticleBMC pediatrics2018

Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study.

Hai Peng Yan, Miao Li, Xiu Lan Lu, Yi Min Zhu, Wen-Xian Ou-Yang, Zheng Hui Xiao, Jun Qiu, Shuang Jie Li

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS).International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. New Perspectives on the Importance of Cell-Free DNA Biology.Diagnostics (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hai Peng YanDepartment of Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
Miao LiDepartment of Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
Xiu Lan LuDepartment of Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
Yi Min ZhuHunan Provincial People's Hospital, the first affiliated hospital of Hunan normal University, Changsha, 410007, People's Republic of China.
Wen-Xian Ou-YangDepartment of Section of Liver Disease, Hunan Children's Hospital, 86# Ziyuan Road, Changsha, 410007, China.
Zheng Hui XiaoDepartment of Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
Jun QiuDepartment of Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
Shuang Jie LiDepartment of Section of Liver Disease, Hunan Children's Hospital, 86# Ziyuan Road, Changsha, 410007, China. correspondetyy@163.com.
Hunan Children's Hospital · CNHunan Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mortality rate due to severe sepsis is approximately 30-60%. Sepsis readily progresses to septic shock and multiple organ dysfunction, representing a significant problem in the pediatric intensive care unit (PICU). The aim of this study was to explore the value of plasma mitochondrial DNA (mtDNA) for early diagnosis and prognosis in children with sepsis.

methodsA total of 123 children with sepsis who were hospitalized in the Hunan Children's Hospital PICU from July 2013 to December 2014 were divided into the general sepsis group (n = 70) and severe sepsis group (n = 53) based on diagnostic standards. An additional 30 children with non-sepsis infection and 30 healthy children were randomly selected as a control group. Patients' plasma was collected during admission to the PICU. A pediatric critical illness score (PCIS) was also calculated. The plasma mtDNA level was examined using real-time polymerase chain reaction technology, and other parameters including routine laboratory values; blood lactate, procalcitonin (PCT), and C-reactive protein (CRP) levels; and data on survival were collected and compared among the groups.

resultsThe plasma mtDNA level in the sepsis group than that in the non-sepsis infection and healthy groups. The plasma mtDNA level was significantly higher in the severe sepsis than in the general sepsis group (p < 0.001). A lower PCIS was associated with a higher plasma mtDNA level (p < 0.001). A higher number of organs with dysfunction was associated with higher plasma mtDNA levels (p < 0.001). Plasma mtDNA levels were higher among patients with elevated alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, creatinine, lactate dehydrogenase, creatine kinase, myoglobin, creatine kinase MB, and troponin than in those with values within the normal range. The mtDNA level was higher among non-survivors than among survivors, and this difference was significant. mtDNA showed a prognostic prediction value similar to that of lactate, PCT, and CRP.

conclusionsPlasma mtDNA levels may be a suitable biomarker for diagnosis and prognosis in children with sepsis.

Indexed as

Patient AcuityBiomarkersCase-Control StudiesChild, PreschoolDNA, MitochondrialFemaleHumansInfantMalePrognosisROC CurveSepsisBiomarkersDNA, MitochondrialBiomarkerMitochondrial DNAMultiorgan failurePrognosisSepsis

Identifiers

PMID30092777
PMCPMC6085664
OpenAlexW2885479095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.